Oliver Adrienne MD - FL Miami-Dade, Miami 33162

Oliver Adrienne MD entered the industry of Unlicensed Nurses Aids in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6213992, which describes it as a Unlicensed Nurses Aids. For further clarification, the SIC classifies this business under the code 8049 and described it as a Unlicensed Nurses Aids. The business provides service to the B2C market.

To acquire more information, please contact Adrienne Oliver by calling (305) 949-0999 during business hours. You can also write to the business’ Single Location at 1431 Ne 162nd St, Miami, Florida FL 33162. You can also visit the company’s website at chenmedicalcenters.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Oliver Adrienne MD
Representative: Adrienne Oliver
Place of Business: 1431 Ne 162nd St, Miami, FL 33162
Contact Number: (305) 949-0999
Website: chenmedicalcenters.com
Type of Service: Unlicensed Nurses Aids
SIC Number: 8049
NAICS Number: 6213992
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Oliver Adrienne MD is a company operating from Miami-Dade, Florida providing professional Unlicensed Nurses Aids and relevant B2C variables. It was founded in 0 and registered with the SIC code 8049 as Unlicensed Nurses Aids, and with the NAICS code 6213992 as Unlicensed Nurses Aids.

With a current employee count of 1 to 4, Oliver Adrienne MD has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Adrienne Oliver at (305) 949-0999 for related queries, or to locate its Single Location using the coordinates 25.92471,-80.17097.

The Single Location can also be found at the street address 1431 Ne 162nd St in Miami, Florida 33162 and can be engaged online through the company website at chenmedicalcenters.com, the company Twitter , and Facebook page .